OAR 855-019-0460
Naloxone - Delivery of Care and Prescribing


(1)

A pharmacist, having determined that there is an identified medical need, can prescribe naloxone and the necessary medical supplies to administer naloxone for opiate overdose:
(a) When dispensing any opiate or opioid prescription in excess of 50 morphine milligram equivalents (MME);
(b) To an individual seeking naloxone;
(c) To an entity seeking naloxone.
(2) The pharmacist shall determine that the individual (or the individual on behalf of an entity) seeking naloxone demonstrates understanding of educational materials related to opioid overdose prevention, recognition, response, and the administration of naloxone.
(3) The pharmacist may prescribe naloxone in any FDA approved dosage form and the necessary medical supplies needed to administer naloxone.
(4) The pharmacist shall dispense the naloxone product in a properly labeled container.
(5) Naloxone may not be prescribed without offering to provide oral counseling to the authorized recipient, which may include dose, effectiveness, adverse effects, storage conditions, and safety.
(6) The pharmacist must document the encounter and the prescription, and maintain records for three years.
(7) Any person, having once lawfully obtained naloxone may possess, distribute or administer it for the purpose of reversing opiate overdose.

Source: Rule 855-019-0460 — Naloxone - Delivery of Care and Prescribing, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-019-0460.

855‑019‑0100
Application
855‑019‑0110
Definitions
855‑019‑0120
Licensure
855‑019‑0122
Renewal of Licensure as a Pharmacist
855‑019‑0123
Liability Limitations for Volunteers
855‑019‑0125
Coaching from Board and Staff
855‑019‑0130
Licensure by Reciprocity
855‑019‑0140
NAPLEX Score Transfer
855‑019‑0150
Foreign Pharmacy Graduates
855‑019‑0160
Nuclear Pharmacists
855‑019‑0170
Reinstatement of License
855‑019‑0171
Reinstatement of a Revoked or Surrendered License
855‑019‑0200
General Responsibilities of a Pharmacist
855‑019‑0205
Duty to Report
855‑019‑0210
Duties of the Pharmacist Receiving a Prescription
855‑019‑0220
Drug Utilization Review (DUR)
855‑019‑0230
Counseling
855‑019‑0240
Consulting Pharmacist Practice
855‑019‑0250
Medication Therapy Management
855‑019‑0260
Collaborative Drug Therapy Management
855‑019‑0265
Administration of Drugs
855‑019‑0270
Immunization Qualifications
855‑019‑0280
Immunization Protocols, Policies and Procedures
855‑019‑0290
Immunization Record Keeping and Reporting
855‑019‑0300
Duties of a Pharmacist-in-Charge
855‑019‑0310
Grounds for Discipline
855‑019‑0400
Contraceptives - Purpose
855‑019‑0405
Contraceptives - Definitions
855‑019‑0410
Prescriptive Practice Consultation
855‑019‑0415
Contraceptive - Training Program
855‑019‑0425
Contraceptive - Procedural Mandates
855‑019‑0430
Contraceptive - Prohibited Practices
855‑019‑0435
Contraceptive - Records
855‑019‑0460
Naloxone - Delivery of Care and Prescribing
855‑019‑0470
Emergency Insulin
Last Updated

Jun. 8, 2021

Rule 855-019-0460’s source at or​.us